Antagonistic effects of endogenous and exogenous tgf-sz and tnf on auto-immune diseases in mice

Immunopharmacology and Immunotoxicology

Volumn 15, Issue 4, 1993, Pages 461-478

  Santambrogio, L ^a   Hochwald, G M ^a   Leu, C H ^a   Thorbecke, G J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; MONOCLONAL ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMAL; ARTHRITIS; AUTOIMMUNE DISEASES; CELL ADHESION MOLECULES; COLLAGEN; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MALE; MICE; MICE, INBRED DBA; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

EID: 0027182385     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979309035240     Document Type: Article

References (47)

1. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide
2. Serum transfer of collagen-induced arthritis in mice
3. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4
4. Experimental synovitis induced by collagen-specific T cell lines
5. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis
6. Cellular cooperation in the expression of murine delayed-type hypersensitivity (DTH) 1. A normal accessory cell population enchances DTH produced by immune peritoneal exudate T lymphocytes
7. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein
8. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis
9. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy
10. Restricted use of T cell receptor V genes in murine autoimmune encephalo- myelitis raises possibilities for antibody therapy
11. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4ßl integrin
12. 1
13. 1
14. Transforming growth factor-ß regulates the adhesive interactions between mononuclear cells and microvascular endothelium
15. Immunosuppressive effects of transforming growth factor ß: Inhibition of the induction of la antigen on Langerhans cells by cytokines and of the contact hypersensitivity response
16. 1 modulates the expression of class II histocompatibility antigens on human cells
17. 1 on experimental autoimmune diseases in mice
18. Involvement of endogenous TNF-α and TGF-ß produced during the induction of collagen type II arthritis in mice
19. Cloning and expression in E
20. Human transforming growth factor beta complementary DNA sequence and expression in normal and transformed cells
21. 1 during lymphocyte activation: A study with monoclonal antibody-based ELISA
22. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors
23. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice
24. 1
25. Role of interferon-γ in counteracting the suppressive effects of transforming growth factor-ß2 and glucocorticoids on the production of tumor necrosis factor-α
26. 1
27. Deactivation of macrophages by transforming growth factor-ß
28. Inhibition of cytotoxic T cell development by transforming growth factor ß and reversal by recombinant tumor necrosis factor
29. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats
30. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells
31. IL-10 synergizes with IL-4 and transforming growth factor-ß to inhibit macrophage cytotoxic activity
32. Cytokine cytotoxicity against oligodendrocytes
33. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
34. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis
35. Evidence of endogenous regulatory function of tranforming growth factor-ß in experimental allergic encephalomyelitis
36. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor ß after antigen-specific triggering
37. Production of transforming growth factor ß by human T lymphocytes and its potential role in the regulation of T cell growth
38. Regulation of rat pulmonary artery endothelial cell transforming growth factor-ß production by IL-1ß and tumor necrosis factor-α
39. Transforming growth factor-ß enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages
40. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor
41. 1
42. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon γ tumor necrosis factor-α and interleukin 1ß
43. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium
44. Phenotypic characterization of synovial tissue cells in situ in different types of synovitis
45. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes
46. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation